Literature DB >> 22407166

Ghrelin signaling in heart remodeling of adult obese mice.

Glauciane Lacerda-Miranda1, Vivian M Soares, Anatalia K G Vieira, Juliana G Lessa, Alessandra C S Rodrigues-Cunha, Erika Cortez, Erica P Garcia-Souza, Anibal S Moura.   

Abstract

Ghrelin, an endogenous ligand of the growth hormone secretagogue receptor (GHS-R), has been suggested to be associated to obesity, insulin secretion, cardiovascular growth and homeostasis. GHS-R has been found in most of the tissues, and among the hormone action it is included the regulation of heart energy metabolism. Therefore, hypernutrition during early life leads to obesity, induces cardiac hypertrophy, compromises myocardial function, inducing heart failure in adulthood. We examined ghrelin signaling process in cardiac remodeling in these obese adult mice. The cardiomyocytes (cmy) of left ventricle were analyzed by light microscopy and stereology, content and phosphorilation of cardiac proteins: ghrelin receptor (growth hormone secretagogue receptor 1a, GHSR-1a), protein kinase B (AKT and pAKT), phosphatidil inositol 3 kinase (PI3K), AMP-activated protein kinase (AMPK and pAMPK) and actin were achieved by Western blotting. GHSR-1a gene expression was analyzed by Real Time-PCR. We observed hyperglycemia and higher liver and visceral fat weight in obese when compared to control group. Obese mice presented a marked increase in heart weight/tibia length, indicating an enlarged heart size or a remodeling process. Obese mice had increased GHSR-1a content and expression in the heart associated to PI3K content and increased AKT content and phosphorylation. In contrast, AMPK content and phosphorylation in heart was not different between experimental groups. Ghrelin plasma levels in obese group were decreased when compared to control group. Our data suggest that remodeled myocardial in adult obese mice overnourished in early life are associated with higher phosphorylation of GHSR-1a, PI3K and AKT but not with AMPK.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407166     DOI: 10.1016/j.peptides.2012.02.025

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  Chronic peripheral ghrelin injection exerts antifibrotic effects by increasing growth differentiation factor 15 in rat hearts with myocardial fibrosis induced by isoproterenol.

Authors:  Q Ren; P Lin; Q Wang; B Zhang; L Feng
Journal:  Physiol Res       Date:  2019-12-19       Impact factor: 1.881

2.  Effects of the use of assisted reproductive technologies and an obesogenic environment on resistance artery function and diabetes biomarkers in mice offspring.

Authors:  Francisco I Ramirez-Perez; Angela L Schenewerk; Katy L Coffman; Christopher Foote; Tieming Ji; Rocio M Rivera; Luis A Martinez-Lemus
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

3.  Potential new role of the GHSR-1a-mediated signaling pathway in cardiac remodeling after myocardial infarction (Review).

Authors:  Ming-Jie Yuan; He Huang; Cong-Xin Huang
Journal:  Oncol Lett       Date:  2014-06-12       Impact factor: 2.967

Review 4.  Therapeutic Potential of Targeting the Ghrelin Pathway.

Authors:  Gustav Colldén; Matthias H Tschöp; Timo D Müller
Journal:  Int J Mol Sci       Date:  2017-04-11       Impact factor: 5.923

Review 5.  Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome.

Authors:  Mohamed Asrih; François Mach; Alessio Nencioni; Franco Dallegri; Alessandra Quercioli; Fabrizio Montecucco
Journal:  Mediators Inflamm       Date:  2013-01-09       Impact factor: 4.711

Review 6.  Heal the heart through gut (hormone) ghrelin: a potential player to combat heart failure.

Authors:  Shreyasi Gupta; Arkadeep Mitra
Journal:  Heart Fail Rev       Date:  2020-10-06       Impact factor: 4.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.